Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. Reply
- PMID: 34758263
- DOI: 10.1056/NEJMc2115204
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. Reply
Comment on
-
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.N Engl J Med. 2021 Nov 11;385(20):1919. doi: 10.1056/NEJMc2115204. N Engl J Med. 2021. PMID: 34758261 No abstract available.
-
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.N Engl J Med. 2021 Nov 11;385(20):1919-1920. doi: 10.1056/NEJMc2115204. N Engl J Med. 2021. PMID: 34758262 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical